Loading insider details...
Beta
Latest Form 4 (Jun 24, 2026): Grant/Award of 3,990 BBIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 3,990 | n/a |
| Mar 16, 2026 | PRECIGEN, INC. (PGEN) | Exercise/Conversion | 71,839 | n/a |
| Mar 12, 2026 | PRECIGEN, INC. (PGEN) | Grant/Award | 17,948 | $63.0K |
| Jan 13, 2026 | Cocrystal Pharma, Inc. (COCP) | Grant/Award | 16,410 | n/a |
| Jan 6, 2026 | EyePoint, Inc. (EYPT) | Grant/Award | 40,000 | n/a |
| Oct 30, 2025 | Cocrystal Pharma, Inc. (COCP) | Grant/Award | 359,713 | $500.0K |
| Jun 24, 2025 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 6,589 | n/a |
| Mar 17, 2025 | PRECIGEN, INC. (PGEN) | Grant/Award | 36,206 | $63.0K |
| Jan 7, 2025 | EyePoint Pharmaceuticals, Inc. (EYPT) | Grant/Award | 40,000 | n/a |
| Oct 11, 2024 | Cocrystal Pharma, Inc. (COCP) | Grant/Award | 8,067 | n/a |